Abstract
Neonatal jaundice (hyperbilirubinemia) is one of the most common conditions that require medical attention in neonates. The medical condition is because of the imbalance between bilirubin production and its excretion. The accumulation of serum bilirubin in excess, elevates the values of bilirubin in neonates up to a high concentration as noted in the medical laboratory assay causing the yellowish colouration of skin and the eye. A retrospective study was carried out in OLA hospital from 2019 t0 2021 for neonates delivered within the period. The incidence of neonatal jaundice (hyperbilirubinemia) in this study was 11.7%. The most common risk factor associated with neonatal jaundice (hyperbilirubinemia) is ABO incompatibility, Preterm gestation and low birth weight (<2.5kg). Neonatal jaundice (hyperbilirubinemia) is a common problem encountered in Neonatal Intensive Care Units of hospitals as seen in OLA Hospital in Jos. The recommended strategies that is involve in the prevention and control of neonatal jaundice include; health education on neonatal jaundice, identification of risk factors, early detection of neonatal jaundice, proper assessment of babies with neonatal jaundice and early referral for good medical management.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
